Tavares

A Biotech Bonanza for ImClone and Dendreon

I am a believer in Provenge, and have been vested in the stock for nearly a year. I took profits on the uptick this week. Held a small position and plan to add back to my position over the next year in preparation that the FDA will do the right thing and approve this drug. See you on the beach this time next year!